COMP <GO>
BKD vs NHC // EV/EBITDA & P/E VALUATION
Brookdale Senior Living Inc. (NYSE) VS. National HealthCare Corporation (NYSE) • 15-METRIC TALLY: BKD 1
— NHC 10
▲ EV/EBITDA & P/E VALUATION LEADER: NHC
LAST: $10.27 (+2.91%) • MKT CAP: $2.45B
valuation
34.6x
LAST: $212.16 (+0.18%) • MKT CAP: $3.32B
valuation
20.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKD VS. NHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKD | NHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.30% | 10.10% | -9.80 | NHC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 34.6x | 20.5x | +14.10 | NHC | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 4.47% | -3.80 | NHC | /fcf-yield <GO> |
| Operating Margin | 0.40% | 8.50% | -8.10 | NHC | /operating-margins <GO> |
| Net Profit Margin | -8.20% | 7.90% | -16.10 | NHC | /net-margins <GO> |
| Revenue Growth (YoY) | 2.20% | 16.10% | -13.90 | NHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.16% | -1.16 | NHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 6.61 | -6.41 | NHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | NHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 35.1 | +13.26 | BKD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.45B | $3.32B | -$870.1M | NHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKD REV | NHC REV | BKD GROSS % | NHC GROSS % | BKD FCF | NHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.19B | $1.52B | 26.2% | — | $16.5M | $148.6M |
| FY 2024 | $3.13B | $1.31B | 25.6% | — | -$35.1M | $79.7M |
| FY 2023 | $3.02B | $1.14B | — | — | $162.9M | $111.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKD // BETA —
NHC // BETA —